Bloomberg TalksBloomberg Talks

Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market

View descriptionShare

Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld. 

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Talks

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in financ 
Social links
Follow podcast
Recent clips
Browse 2,618 clip(s)